RELUGONAT (Relugolix 120mg) x 30 Tablets

Uses of Relugolix 120 mg

• Treats advanced prostate cancer.
• Used for hormone-sensitive prostate cancer.
• Helps lower testosterone levels in men.
• Sometimes used in uterine fibroids and endometriosis (in lower-dose combinations, as prescribed).

Benefits of Relugolix 120 mg

• Reduces testosterone quickly and effectively.
• Helps slow growth of prostate cancer cells.
• Oral alternative to injectable hormone therapies.
• May reduce cancer-related symptoms like bone pain.
• Faster hormonal suppression compared to some injections.

How does it work?

Relugolix is a GnRH receptor antagonist. It blocks signals from the brain (pituitary gland) that stimulate testosterone production. This leads to a rapid drop in testosterone levels, which helps control hormone-dependent cancers like prostate cancer.

Precautions

• Take exactly as prescribed, at the same time each day.
• Do not stop suddenly without medical advice.
• Inform your doctor about heart disease or clotting risk.
• Tell your doctor about all medicines you are taking.
• Monitor for hot flashes, fatigue, or bone loss.
• Not recommended during pregnancy.
• Report chest pain, swelling, or severe weakness immediately.

Side Effects

• Hot flashes
• Fatigue
• Diarrhea
• Increased blood sugar levels
• Joint or muscle pain

Relugonat (Relugolix 120mg) Tablets available at affordable rates from our generic pharmacy

We provide genuine Relugonat (Relugolix 120mg) Tablets, a targeted oral therapy used in the treatment of advanced hormone-sensitive prostate cancer by reducing testosterone levels that promote cancer growth.

As a leading global pharmaceutical wholesaler, we deliver high‑quality generic oncology medicines to healthcare providers and distributors in markets such as Colombia, Peru, the Philippines, Venezuela, Panama, Ecuador, Namibia, South Africa, Zimbabwe, Bahrain, Cyprus, Egypt, Iran, Iraq, Israel, Jordan, Palestine, Qatar, Saudi Arabia, the United Arab Emirates, China, Canada, Brazil, Mexico, Russia, Thailand, Malaysia, Singapore, Vietnam, South Korea, Taiwan, Indonesia, the United States, and more.